IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma

Multidimensional analyses demonstrate that repeated DeltEx DRI dosing preserves immune function, drives tumor microenvironment remodeling, and ...
Frontiers

Targeting spatial immune diversity in head and neck cancer for improved therapeutic strategies

Head and neck cancers display notable heterogeneity in their immune cell infiltrates, which reflect intricate spatial arrangements and dynamic networks of ...
Labroots

Introduction to Spatial Single-Cell Transcriptomics Technology and Analytics

Spatial transcriptomics is revolutionizing the study of tissue architecture, cellular states, and tumor-immune interactions in clinical specimens. This presentation introduces the principles and ...
Medical Xpress

Single-cell tool predicts cancer survival by pinpointing harmful tumor cells

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival using advanced molecular data from individual cells. Survival analysis is ...
Technology Networks

Mapping the Tumor Microenvironment With a Blood Test

A new blood test profiles tumor microenvironment ecotypes via cell-free DNA methylation—correlating with biopsy findings and ...
Morningstar

Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and ...